Rare benign breast tumor

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:180253D24
Who is this for?
Show terms as
1FDA treatments8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Rare benign breast tumors (ICD-10: D24) encompass a heterogeneous group of uncommon non-cancerous neoplasms arising in breast tissue. These tumors are classified under Orphanet code 180253 and include a variety of histological subtypes such as granular cell tumors of the breast, adenomyoepitheliomas, myofibroblastomas, lipomas, leiomyomas, and other unusual benign proliferations that do not fall into the more common categories of fibroadenoma or phyllodes tumor. These lesions primarily affect the breast and surrounding soft tissues, and they typically present as a palpable, painless breast mass that may be discovered incidentally on imaging or during routine clinical examination. Clinically, patients most often notice a firm or mobile lump in the breast, which may grow slowly over time. Because these tumors are benign, they do not metastasize; however, they can sometimes mimic malignant lesions on mammography or ultrasound, leading to diagnostic uncertainty that necessitates biopsy for definitive characterization. Some subtypes may cause localized breast discomfort, skin changes, or nipple discharge, though many remain asymptomatic. The condition can affect individuals of any age but is most commonly diagnosed in adults. Treatment typically involves surgical excision, particularly when the tumor causes symptoms, grows significantly, or when the diagnosis remains uncertain after imaging and core needle biopsy. Complete surgical removal is generally curative, with low recurrence rates for most subtypes. In cases where the diagnosis is confirmed and the tumor is small and asymptomatic, clinical and imaging surveillance may be an appropriate management strategy. Prognosis is excellent, as these tumors carry no risk of malignant transformation in most subtypes, though regular follow-up may be recommended depending on the specific histological diagnosis.

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

1 available

Omeprazole

OMEPRAZOLE· PD-Rx Pharmaceuticals, Inc.

Treatment of active benign gastric ulcer in adults

No actively recruiting trials found for Rare benign breast tumor at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Rare benign breast tumor community →

No specialists are currently listed for Rare benign breast tumor.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Rare benign breast tumor.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Rare benign breast tumorForum →

No community posts yet. Be the first to share your experience with Rare benign breast tumor.

Start the conversation →

Latest news about Rare benign breast tumor

No recent news articles for Rare benign breast tumor.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Rare benign breast tumor

What is Rare benign breast tumor?

Rare benign breast tumors (ICD-10: D24) encompass a heterogeneous group of uncommon non-cancerous neoplasms arising in breast tissue. These tumors are classified under Orphanet code 180253 and include a variety of histological subtypes such as granular cell tumors of the breast, adenomyoepitheliomas, myofibroblastomas, lipomas, leiomyomas, and other unusual benign proliferations that do not fall into the more common categories of fibroadenoma or phyllodes tumor. These lesions primarily affect the breast and surrounding soft tissues, and they typically present as a palpable, painless breast mas

How is Rare benign breast tumor inherited?

Rare benign breast tumor follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Rare benign breast tumor typically begin?

Typical onset of Rare benign breast tumor is adult. Age of onset can vary across affected individuals.